Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc. (IKT)

Market is closed
News
  • Displaying 8
Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q2 2024 Earnings Call Transcript

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q2 2024 Earnings Call Transcript

Operator: Greetings and welcome to the Inhibikase Therapeutics Second Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

August 16th, 2024 - News Transcripts

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q1 2024 Earnings Call Transcript

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q1 2024 Earnings Call Transcript

Operator: Greetings and welcome to Inhibikase Therapeutics First Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Keep Reading →

May 19th, 2024 - News Transcripts

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q4 2023 Earnings Call Transcript

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q4 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Greetings, and welcome to Inhibikase Therapeutics Fourth Quarter and Full Year 2023 Financial Results.

Keep Reading →

April 2nd, 2024 - News Transcripts

5 Cheap Small-Cap Stocks to Buy Before the Next Breakout

5 Cheap Small-Cap Stocks to Buy Before the Next Breakout

In this piece, we will take a look at five cheap small cap stocks to buy before the next breakout.

Keep Reading →

August 31st, 2023 - News Quantitative Investing

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q2 2023 Earnings Call Transcript

Operator: Good morning. Welcome to the Inhibikase Therapeutics Second Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.

Keep Reading →

August 17th, 2023 - News Transcripts

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q1 2023 Earnings Call Transcript

Operator: Good morning and welcome to the Inhibikase Therapeutics First Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode.

Keep Reading →

May 17th, 2023 - News Transcripts

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q4 2022 Earnings Call Transcript

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q4 2022 Earnings Call Transcript

Operator: Good morning and welcome to the Inhibikase Fourth Quarter and Full Year 2022 Earnings Conference Call. Please note, today's event is being recorded.

Keep Reading →

April 7th, 2023 - News Transcripts

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q3 2022 Earnings Call Transcript

Operator: Good day, and welcome to Inhibikase Therapeutics' Third Quarter 2022 Financial Results Conference Call. All participants are in listen-only mode. Please note, this event is being recorded.

Keep Reading →

December 28th, 2022 - News Transcripts

Insider Monkey Quarterly Strategy
+336.2% Insider Monkey Quarterly Strategy
+144.8% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)